blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4110760

EP4110760 - GPR40 AGONISTS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.12.2022
Database last updated on 05.10.2024
FormerThe international publication has been made
Status updated on  03.09.2021
Most recent event   Tooltip22.08.2024Supplementary search reportpublished on 18.09.2024  [2024/38]
Applicant(s)For all designated states
Kallyope, Inc.
430 East 29th Street, 10th Floor
New York, New York 10016 / US
[2023/01]
Inventor(s)01 / SEBHAT, Iyassu
430 East 29th Street 10th Floor
New York, New York 10016 / US
02 / HE, Shuwen
430 East 29th Street 10th Floor
New York, New York 10016 / US
03 / MATHIEU, Simon
430 East 29th Street 10th Floor
New York, New York 10016 / US
 [2023/01]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2023/01]
Application number, filing date21759537.026.02.2021
[2023/01]
WO2021US19973
Priority number, dateUS202062983438P28.02.2020         Original published format: US 202062983438 P
US202063076113P09.09.2020         Original published format: US 202063076113 P
US202063117074P23.11.2020         Original published format: US 202063117074 P
US202163147982P10.02.2021         Original published format: US 202163147982 P
[2023/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021174046
Date:02.09.2021
Language:EN
[2021/35]
Type: A1 Application with search report 
No.:EP4110760
Date:04.01.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.2021 takes the place of the publication of the European patent application.
[2023/01]
Search report(s)International search report - published on:KR02.09.2021
(Supplementary) European search report - dispatched on:EP21.08.2024
ClassificationIPC:C07D213/64, C07D241/12, C07F5/04, C07F9/30, C07F9/58, C07F9/6509, C07F9/6558, A61K31/155, A61K31/4418, A61K31/662, A61K31/675, A61K45/06, A61P3/00, A61P1/16
[2024/38]
CPC:
C07F9/58 (EP,US); A61K31/155 (EP); A61K31/4418 (EP,US);
A61K31/662 (EP,US); A61K31/675 (EP,US); A61K45/06 (EP,US);
A61P1/16 (EP); A61P3/00 (EP); C07D213/64 (EP,US);
C07D241/12 (EP); C07F9/306 (EP,US); C07F9/650952 (EP);
C07F9/65583 (EP,US) (-)
C-Set:
A61K31/155, A61K2300/00 (EP);
A61K31/4418, A61K2300/00 (EP);
A61K31/662, A61K2300/00 (EP);
A61K31/675, A61K2300/00 (EP)
Former IPC [2023/01]C07D213/64, C07F9/38, C07F9/32, A61K31/4418, A61K31/675, A61K31/662, A61P3/00, A61P1/16
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/01]
TitleGerman:GPR40-AGONISTEN[2023/01]
English:GPR40 AGONISTS[2023/01]
French:AGONISTES DE GPR40[2023/01]
Entry into regional phase23.08.2022National basic fee paid 
23.08.2022Search fee paid 
23.08.2022Designation fee(s) paid 
23.08.2022Examination fee paid 
Examination procedure23.08.2022Examination requested  [2023/01]
14.04.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.02.2023Renewal fee patent year 03
27.02.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2012011125  (CONNEXIOS LIFE SCIENCES PVT LTD [IN], et al);
 [X]US2015018422  (MIWATASHI SEIJI [JP], et al);
 [X]US2016009662  (MEEGALLA SANATH [US], et al);
 [X]US2016332968  (CHOBANIAN HARRY [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.